6Poovala VS, Huang H, Salahudeen AK. Role of reactive oxygen metabolites In organophosphate-bidrin-induced renal tubular cytotoxicity [J]. J Am Soc Nephrol, 1999, 10 (8):1746-1752.
7Aymerich MS, Bengoechea-Alonso MT, Lopez-Zabalza MJ,et al. Inducible Nitric oxide synthase (iNOS) expression in human monocytes triggered by B β-en- Dorphin through an inSerase in cAMP [J ]. Biochem Biophys Res Commun,1998, 245 (3): 717-721.
6Kato M, Shitara Y, Sato H, et al. The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling[J]. Pharm Res, 2008, 25(8): 1891- 1901.
7Pery AR, Devillers J, Brothot C, et al. A physiologically based toxieokinetic model for the zebrafish Danio rerio[J]. Environ SciTechnol, 2014, 48(1): 781-790.
8Moser VC. Age-and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats[J]. Toxicol Appl Pharm, 1998, 149(1): 107-119.
9Marty MS, Andrus AK, Bell MP, et al. Cholinesterase inhibition and toxicokinetics in immature and adult rats after acute or repeated exposures to chlorpyrifos or chlorpyrifos-oxon[J]. RegulToxicolPharm, 2012, 63(2): 209-224.
10Timchalk C, Nolan R J, Mendrala AL, et al. A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans[J]. ToxicolSci, 2002, 66(1): 34-53.
